Suggestions
Axel Heitmueller
Managing Director at Imperial College Health Partners
Axel Heitmueller is a prominent figure in healthcare innovation and policy with extensive experience in both the public and private sectors. Here are the key details about his career and current roles:
Current Positions
-
Chief Executive Officer: Axel Heitmueller is currently the CEO of Imperial College Health Partners, an innovation agency working within the NHS.13
-
Senior Associate Fellow: He holds this position at the Tony Blair Institute for Global Change, a role he has occupied since April 2022.5
-
Visiting Professor: Heitmueller is a Visiting Professor at the Institute of Global Health Innovation at Imperial College London.13
Professional Background
Government Experience::
- Served as Deputy Director and Chief Analyst at the Prime Minister's Strategy Unit in the Cabinet Office and No 10.13
- Worked as National Director for Innovation and Testing Strategy at NHS Test and Trace.1
Healthcare Leadership::
- Prior to his current role, he was Executive Director of Strategy and Business Development at Chelsea and Westminster Hospital NHS Foundation Trust.3
- Joined Imperial College Health Partners in 2013 as Director of Strategy and Commerce before becoming Managing Director in September 2016.3
Education
Heitmueller holds advanced degrees in economics:
- Master's degree in Economics
- PhD in Economics4
Expertise and Contributions
Axel Heitmueller is known for his work in healthcare innovation, strategy, and policy. He has contributed to various publications and initiatives focused on improving public health services, NHS reform, and leveraging data for healthcare advancements.2 His experience spans academia, government, and healthcare management, giving him a comprehensive perspective on health system challenges and potential solutions.
Highlights
Many thanks for the great responses, comments, and suggestions to our proposal for a radically different fiscal approach to health - a genuine National Health Insurance model.
This may sound boring and technical but it is urgently needed if we are serious about health=growth and our desire to not just treat illness, but maximise the health of the nation.
Multi-year funding is one part of this model that will help unlock opportunities for population health investment as well as wider innovation which is currently hampered by in-year ROI requirements.
All of this is part of a wider change in the operating model for healthcare in the UK that is required - unless we provide the incentives and motivation for change and increase the absorptive capacity of organisations, innovation will not happen at pace or the scale needed. We can forever marvel at the opportunities in front of us, they will simply not happen if we continue on the current path.
For too long we have solely focused on the supply side of innovation (accelerators, incubators etc), neglecting the much harder task of enabling the adoption. A new innovation strategy will not suffice. We need a clear operating model for our health service that enables and incentives change and moves us away from the command-and-control culture we have.
The 10 year plan provides the opportunity to set out such a new operating model - in our view, many of the components are well known and the transition is possible without the downsides of massive structural change and disruption by building on and empowering ICBs.
Tony Blair Institute for Global Change Darcy Ward Adam Bradshaw Dr Charlotte Refsum Henry Li Oliver Large
Is there a better way to organise and fund old age? Much has been written about social care funding but this paper by Camilla Cavendish Gabriel Moberg and Jessica Freedman offers some new perspectives - and importantly attempts to move towards a positive narrative of aging.
